Warburg Research set a €50.00 ($58.14) price objective on Brenntag (FRA:BNR) in a research report report published on Thursday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stock.
Several other research analysts also recently weighed in on BNR. Jefferies Financial Group dropped their target price on shares of Seres Therapeutics from $6.00 to $4.00 and set a hold rating on the stock in a research report on Monday, July 1st. JPMorgan Chase & Co. set a €50.00 ($58.14) target price on shares of Brenntag and gave the stock a buy rating in a research report on Tuesday, July 16th. Kepler Capital Markets set a €112.00 ($130.23) target price on shares of LEG Immobilien and gave the stock a buy rating in a research report on Thursday, May 9th. Berenberg Bank set a €14.00 ($16.28) target price on shares of Suedzucker and gave the stock a neutral rating in a research report on Wednesday, July 17th. Finally, Baader Bank set a €50.00 ($58.14) target price on shares of Brenntag and gave the stock a buy rating in a research report on Wednesday, July 17th. Four analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. The company has an average rating of Buy and an average price target of €52.77 ($61.36).
FRA BNR opened at €43.60 ($50.70) on Thursday. The stock has a 50 day simple moving average of €43.04. Brenntag has a 12 month low of €43.06 ($50.07) and a 12 month high of €56.25 ($65.41).
Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.
Featured Story: Gap Down Stocks
Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.